StopDownOpen the app

Stake sale · Commerce & Consumer Brands

Venture Catalysts exits Pee Safe with 9.6x return via secondary sale

By ·

Date
Company
Venture Catalysts
What it does
early-stage investment platform
Kind
Stake sale
Amount
$32 Mn
Stage
secondary
Sector
Commerce & Consumer Brands

What they do

Venture Catalysts, an early-stage investment platform, sold its stake in Pee Safe, a women’s hygiene brand, through a secondary sale as part of a Series C…

What happened

The exit delivered a 9.6x return on invested capital (MOIC) and a 30.53% XIRR for Venture Catalysts’ limited partners

Why it matters

Pee Safe has grown significantly since 2017, expanding from a niche toilet seat sanitizer brand to an omnichannel wellness company with a presence in over…

The details

  • Venture Catalysts, an early-stage investment platform, has fully exited its stake in Pee Safe, a women’s hygiene brand, through a secondary sale as part of a Series C round led by OrbiMed.
  • The exit was facilitated by global healthcare private equity firm OrbiMed, which led the Series C round.
  • Venture Catalysts achieved a 9.6x return on invested capital (MOIC) and a 30.53% XIRR for its limited partners.
  • The exit was finalized in January 2026, marking a significant milestone for Venture Catalysts and Pee Safe.
  • Venture Catalysts first invested in Pee Safe in August 2017 during the brand’s pre-Series funding stage.

The bigger picture

  • The exit highlights a growing trend of secondary sales in the Indian startup ecosystem, allowing early-stage backers to realize gains.
  • Pee Safe has grown significantly since 2017, expanding from a niche toilet seat sanitizer brand to an omnichannel wellness company.
  • Pee Safe now has a presence in over 50,000 offline locations across 100+ cities and has seen consistent year-on-year revenue growth of 45–50% over the last 24 months.

About the business

  • Pee Safe is a women’s hygiene brand that has expanded its product portfolio to include period care, grooming, and intimate hygiene products.
  • The company has grown from a niche toilet seat sanitizer brand to a comprehensive wellness company.
  • Pee Safe operates across quick commerce, e-commerce, and direct-to-consumer (D2C) channels.
  • The brand has established a strong retail footprint with a presence in over 50,000 offline touchpoints across 100+ cities.
  • Pee Safe has seen consistent year-on-year revenue growth of 45–50% over the last 24 months.

The deal

Type
stake-sale

Investors

  • OrbiMed (lead) — global healthcare private equity firm

Read it as a card in the app

More on Venture Catalysts

Everything on Venture Catalysts →

Same day

All startup news on 17 March 2026 →